Millennium Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-375,049
| Closed | -$4.63M | – | 6603 |
|
|
2024
Q4 | $4.63M | Sell |
375,049
-3,813,954
| -91% | -$43.7M | ﹤0.01% | 2882 |
|
|
2024
Q3 | $47.7M | Sell |
4,189,003
-910,526
| -18% | -$9.14M | 0.02% | 847 |
|
|
2024
Q2 | $36.4M | Buy |
5,099,529
+695,512
| +16% | +$5.32M | 0.02% | 1012 |
|
|
2024
Q1 | $29.5M | Buy |
4,404,017
+163,870
| +4% | +$1.13M | 0.01% | 1212 |
|
|
2023
Q4 | $27.6M | Buy |
4,240,147
+4,181,060
| +7,076% | +$26.9M | 0.01% | 1271 |
|
|
2023
Q3 | $558K | Buy |
+59,087
| New | +$711K | ﹤0.01% | 4588 |
|
|
2023
Q2 | – | Sell |
-60,659
| Closed | -$1.14M | – | 6818 |
|
|
2023
Q1 | $1.14M | Buy |
60,659
+44,085
| +266% | +$724K | ﹤0.01% | 3967 |
|
|
2022
Q4 | $228K | Sell |
16,574
-11,091
| -40% | -$170K | ﹤0.01% | 5253 |
|
|
2022
Q3 | $529K | Sell |
27,665
-62,620
| -69% | -$1.14M | ﹤0.01% | 4925 |
|
|
2022
Q2 | $1.38M | Buy |
90,285
+49,262
| +120% | +$729K | ﹤0.01% | 4072 |
|
|
2022
Q1 | $836K | Buy |
+41,023
| New | +$835K | ﹤0.01% | 4704 |
|
|
2021
Q4 | – | Sell |
-490,459
| Closed | -$14M | – | 7498 |
|
|
2021
Q3 | $10.6M | Buy |
490,459
+241,037
| +97% | +$5.82M | 0.01% | 1983 |
|
|
2021
Q2 | $6.4M | Buy |
249,422
+50,583
| +25% | +$1.08M | ﹤0.01% | 2434 |
|
|
2021
Q1 | $3.63M | Sell |
198,839
-452,872
| -69% | -$7.52M | ﹤0.01% | 2944 |
|
|
2020
Q4 | $7.52M | Sell |
651,711
-2,027,273
| -76% | -$18.5M | 0.01% | 2064 |
|
|
2020
Q3 | $20.4K | Buy |
2,678,984
+633,918
| +31% | +$4.8M | 0.03% | 790 |
|
|
2020
Q2 | $13.4M | Buy |
2,045,066
+1,344,897
| +192% | +$7.51M | 0.02% | 1007 |
|
|
2020
Q1 | $3.58M | Sell |
700,169
-330,454
| -32% | -$2M | 0.01% | 1595 |
|
|
2019
Q4 | $7.91M | Buy |
1,030,623
+203,339
| +25% | +$1.19M | 0.01% | 1577 |
|
|
2019
Q3 | $4.38M | Buy |
827,284
+804,833
| +3,585% | +$5M | 0.01% | 1914 |
|
|
2019
Q2 | $126K | Sell |
22,451
-11,097
| -33% | -$45.8K | ﹤0.01% | 3857 |
|
|
2019
Q1 | $143K | Sell |
33,548
-5,550
| -14% | -$22.6K | ﹤0.01% | 3800 |
|
|
2018
Q4 | $160K | Sell |
39,098
-119,556
| -75% | -$624K | ﹤0.01% | 3452 |
|
|
2018
Q3 | $1.09M | Buy |
158,654
+118,032
| +291% | +$700K | ﹤0.01% | 2829 |
|
|
2018
Q2 | $159K | Sell |
40,622
-138,253
| -77% | -$480K | ﹤0.01% | 3601 |
|
|
2018
Q1 | $522K | Buy |
+178,875
| New | +$553K | ﹤0.01% | 3002 |
|
|
2017
Q3 | – | Sell |
-4,129
| Closed | -$18K | – | 3940 |
|
|
2017
Q2 | $18K | Sell |
4,129
-5,070
| -55% | -$20.8K | ﹤0.01% | 3387 |
|
|
2017
Q1 | $42K | Buy |
+9,199
| New | +$30.8K | ﹤0.01% | 3399 |
|
|
2016
Q4 | – | Sell |
-73,486
| Closed | -$221K | – | 3824 |
|
|
2016
Q3 | $221K | Sell |
73,486
-87,334
| -54% | -$235K | ﹤0.01% | 2939 |
|
|
2016
Q2 | $410K | Buy |
+160,820
| New | +$448K | ﹤0.01% | 2583 |
|
|
2016
Q1 | – | Sell |
-155,533
| Closed | -$1.27M | – | 3734 |
|
|
2015
Q4 | $1.27M | Buy |
155,533
+22,953
| +17% | +$185K | ﹤0.01% | 2182 |
|
|
2015
Q3 | $947K | Buy |
132,580
+69,805
| +111% | +$583K | ﹤0.01% | 2307 |
|
|
2015
Q2 | $576K | Buy |
62,775
+16,555
| +36% | +$159K | ﹤0.01% | 2570 |
|
|
2015
Q1 | $437K | Buy |
46,220
+32,987
| +249% | +$318K | ﹤0.01% | 2825 |
|
|
2014
Q4 | $129K | Buy |
+13,233
| New | +$133K | ﹤0.01% | 3734 |
|
|
2014
Q1 | – | Sell |
-11,110
| Closed | -$108K | – | 3964 |
|
|
2013
Q4 | $108K | Buy |
+11,110
| New | +$105K | ﹤0.01% | 3336 |
|
|
2013
Q3 | – | Sell |
-24,153
| Closed | -$218K | – | 3633 |
|
|
2013
Q2 | $218K | Buy |
+24,153
| New | +$253K | ﹤0.01% | 2718 |
|
Other funds holding CDMO
Millennium Management's CDMO Position: Q1 2025 in Review
Millennium Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 375,049 shares — an estimated $4.63M sold.
Millennium Management first reported a position in CDMO in Q2 2013 and held it in 37 quarters. The position peaked at $47.7M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Millennium Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Millennium Management sold 375,049 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $4.63M.
- Millennium Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
- Millennium Management's Avid Bioservices, Inc. Common Stock position peaked at $47.7M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.